GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus

Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP...

Full description

Saved in:
Bibliographic Details
Published in:npj vaccines Vol. 8; no. 1; pp. 73 - 17
Main Authors: Scher, Gabrielle, Bente, Dennis A., Mears, Megan C., Cajimat, Maria N. B., Schnell, Matthias J.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 20.05.2023
Nature Publishing Group
Nature Portfolio
Subjects:
631/250/590/1883
631/326/596/2561
Biomedical and Life Sciences
Biomedicine
Glycoproteins
Hemorrhage
Infectious Diseases
Medical Microbiology
Monoclonal antibodies
Parasitic diseases
Public Health
Rodents
Vaccine
Vaccines
Viral infections
Virology
ISSN:2059-0105, 2059-0105
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP38 glycoprotein protected mice against lethal CCHFV challenge. To show that GP38 is required and sufficient for protection against CCHFV, we used three inactivated rhabdoviral-based CCHFV-M vaccines, with or without GP38 in the presence or absence of the other CCHFV glycoproteins. All three vaccines elicited strong antibody responses against the respective CCHFV glycoproteins. However, only vaccines containing GP38 showed protection against CCHFV challenge in mice; vaccines without GP38 were not protective. The results of this study establish the need for GP38 in vaccines targeting CCHFV-M and demonstrate the efficacy of a CCHFV vaccine candidate based on an established vector platform.
AbstractList Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP38 glycoprotein protected mice against lethal CCHFV challenge. To show that GP38 is required and sufficient for protection against CCHFV, we used three inactivated rhabdoviral-based CCHFV-M vaccines, with or without GP38 in the presence or absence of the other CCHFV glycoproteins. All three vaccines elicited strong antibody responses against the respective CCHFV glycoproteins. However, only vaccines containing GP38 showed protection against CCHFV challenge in mice; vaccines without GP38 were not protective. The results of this study establish the need for GP38 in vaccines targeting CCHFV-M and demonstrate the efficacy of a CCHFV vaccine candidate based on an established vector platform.Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP38 glycoprotein protected mice against lethal CCHFV challenge. To show that GP38 is required and sufficient for protection against CCHFV, we used three inactivated rhabdoviral-based CCHFV-M vaccines, with or without GP38 in the presence or absence of the other CCHFV glycoproteins. All three vaccines elicited strong antibody responses against the respective CCHFV glycoproteins. However, only vaccines containing GP38 showed protection against CCHFV challenge in mice; vaccines without GP38 were not protective. The results of this study establish the need for GP38 in vaccines targeting CCHFV-M and demonstrate the efficacy of a CCHFV vaccine candidate based on an established vector platform.
Abstract Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP38 glycoprotein protected mice against lethal CCHFV challenge. To show that GP38 is required and sufficient for protection against CCHFV, we used three inactivated rhabdoviral-based CCHFV-M vaccines, with or without GP38 in the presence or absence of the other CCHFV glycoproteins. All three vaccines elicited strong antibody responses against the respective CCHFV glycoproteins. However, only vaccines containing GP38 showed protection against CCHFV challenge in mice; vaccines without GP38 were not protective. The results of this study establish the need for GP38 in vaccines targeting CCHFV-M and demonstrate the efficacy of a CCHFV vaccine candidate based on an established vector platform.
Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective vaccines and therapeutics against CCHFV for humans, as none are currently internationally approved. Recently, a monoclonal antibody against the GP38 glycoprotein protected mice against lethal CCHFV challenge. To show that GP38 is required and sufficient for protection against CCHFV, we used three inactivated rhabdoviral-based CCHFV-M vaccines, with or without GP38 in the presence or absence of the other CCHFV glycoproteins. All three vaccines elicited strong antibody responses against the respective CCHFV glycoproteins. However, only vaccines containing GP38 showed protection against CCHFV challenge in mice; vaccines without GP38 were not protective. The results of this study establish the need for GP38 in vaccines targeting CCHFV-M and demonstrate the efficacy of a CCHFV vaccine candidate based on an established vector platform.
ArticleNumber 73
Author Mears, Megan C.
Cajimat, Maria N. B.
Schnell, Matthias J.
Scher, Gabrielle
Bente, Dennis A.
Author_xml – sequence: 1
  givenname: Gabrielle
  orcidid: 0000-0002-7571-4791
  surname: Scher
  fullname: Scher, Gabrielle
  organization: Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University
– sequence: 2
  givenname: Dennis A.
  orcidid: 0000-0002-5150-7368
  surname: Bente
  fullname: Bente, Dennis A.
  organization: Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch
– sequence: 3
  givenname: Megan C.
  surname: Mears
  fullname: Mears, Megan C.
  organization: Department of Pathology, University of Texas Medical Branch
– sequence: 4
  givenname: Maria N. B.
  surname: Cajimat
  fullname: Cajimat, Maria N. B.
  organization: Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch
– sequence: 5
  givenname: Matthias J.
  orcidid: 0000-0001-9040-9405
  surname: Schnell
  fullname: Schnell, Matthias J.
  email: Matthias.Schnell@jefferson.edu
  organization: Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Jefferson Vaccine Center, Sidney Kimmel Medical College, Thomas Jefferson University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37210392$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9vFCEYxompsbX2C3gwk3jxMgrDv-FkdKO1SRM96JkA8zLLZhYqzGzit5fdbbXtoSfewPP88gDPS3QSUwSEXhP8nmDafyiMcEZa3NEWYyFoy5-hsw5z1WKC-cm9-RRdlLLBGBMpKJf4BTqlsqsQ1Z2hz5c_aN-Y0phmZ5wLEZrZ5BHmxqfcrHLYgontKsUxNWvYppzXZgyu8bCD3OxCXsor9NybqcDF7XqOfn398nP1rb3-fnm1-nTduhp0bqn0jAnLrZLcyt5gJi0z3FrjlXPKOwCJHacUeDewnnZCEVIniq2V1Hp6jq6O3CGZjb6p0Uz-o5MJ-rCR8qhNnoObQEvBPCYDKAaSCQEGS6MkFo7ZwVvpKuvjkXWz2C0MDuKczfQA-vAkhrUe004TTJQSQlXCu1tCTr8XKLPehuJgmkyEtBTd9URIrgTbS98-km7SkmN9q4OqY_Wqsqre3I_0L8vdX1VBfxS4nErJ4LULs5lD2icMU42m983Qx2bo2gx9aIbm1do9st7RnzTRo6lUcRwh_4_9hOsvXe_IxQ
CitedBy_id crossref_primary_10_1016_j_ebiom_2025_105857
crossref_primary_10_1038_s41541_024_00931_y
crossref_primary_10_1016_j_antiviral_2025_106282
crossref_primary_10_3390_vaccines12010078
crossref_primary_10_1038_s41541_025_01238_2
crossref_primary_10_1093_inthealth_ihaf056
crossref_primary_10_1038_s41541_025_01164_3
crossref_primary_10_1126_scitranslmed_adq5928
crossref_primary_10_3390_v16030378
crossref_primary_10_3390_v16071107
crossref_primary_10_1016_j_antiviral_2024_106045
crossref_primary_10_1128_jvi_00537_25
crossref_primary_10_1016_j_cell_2024_11_008
crossref_primary_10_1016_j_ebiom_2025_105698
Cites_doi 10.1038/s41598-019-44210-6
10.1016/j.ebiom.2022.104188
10.1371/journal.pntd.0003579
10.1016/j.vaccine.2017.05.031
10.1128/JVI.77.16.8640-8649.2003
10.1007/s10875-006-9044-0
10.1038/srep35819
10.1073/pnas.1005201108
10.1093/infdis/jiz332
10.1128/jvi.01568-21
10.1371/journal.ppat.1003389
10.1089/vbz.2015.1855
10.1126/sciadv.aaw9535
10.3390/v11010075
10.1093/infdis/jiw231
10.1128/JVI.02040-16
10.1016/j.cell.2021.05.001
10.1038/s41467-018-06741-w
10.4049/jimmunol.171.8.3928
10.1016/S1473-3099(06)70435-2
10.1007/s10439-019-02398-8
10.1371/journal.pntd.0007800
10.1038/mtm.2014.46
10.1093/infdis/jit061
10.1128/jvi.62.9.3128-3134.1988
10.1128/JVI.77.1.237-244.2003
10.1093/jmedent/15.4.307
10.4049/jimmunol.0900319
10.1371/journal.pone.0091516
10.1126/scitranslmed.aat4615
10.1086/317537
10.1128/JVI.02308-14
10.1371/journal.pntd.0005908
10.1128/JVI.00784-09
10.3390/v13020353
10.1586/14760584.2016.1140040
10.1016/j.coviro.2020.09.003
10.1016/j.diagmicrobio.2013.12.015
10.1098/rstb.2000.0577
10.1128/JVI.80.1.514-525.2006
10.1128/JVI.00558-11
10.1073/pnas.93.14.7310
10.1074/jbc.M110.216515
10.1002/j.1460-2075.1994.tb06739.x
10.1371/journal.pntd.0006628
10.1128/JVI.01865-18
10.1016/j.vaccine.2016.09.058
10.1097/CCM.0000000000003967
10.1016/j.vaccine.2010.03.039
10.1016/j.antiviral.2013.07.006
10.4049/jimmunol.136.2.692
10.1371/journal.ppat.1008850
10.1371/journal.ppat.1005276
10.1038/s41541-021-00293-9
10.1016/0168-1702(92)90032-5
10.1016/j.antiviral.2004.08.001
10.1099/0022-1317-70-6-1513
10.1093/infdis/jiv251
10.1006/clin.1994.1088
10.1038/s41564-018-0141-7
10.1016/j.virol.2006.05.010
10.1007/s00281-018-0726-5
10.1111/apm.12927
10.1128/jvi.70.4.2318-2323.1996
10.1016/S0022-1759(98)00015-5
10.1038/s41564-020-00815-6
10.1073/pnas.93.21.11359
10.1371/journal.pone.0156637
10.1016/j.vaccine.2008.09.082
10.1128/JVI.02327-07
10.1016/j.vaccine.2012.08.003
10.1128/JVI.02076-16
10.1056/NEJMoa2114583
10.1007/s00705-016-2803-1
10.1016/B978-0-12-144730-4.50019-9
10.3389/fphys.2012.00064
10.1097/QCO.0b013e3282a56a0a
10.4049/jimmunol.0800596
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
88C
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M0T
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1038/s41541-023-00663-5
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database (ProQuest)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database (ProQuest)
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Public Health
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 2059-0105
EndPage 17
ExternalDocumentID oai_doaj_org_article_764f01de94e7466ea07a9706c4bdfb7c
PMC10199669
37210392
10_1038_s41541_023_00663_5
Genre Journal Article
GrantInformation_xml – fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
  grantid: T32AI134646; T32AI134646
  funderid: https://doi.org/10.13039/100006492
– fundername: NIAID NIH HHS
  grantid: R01 AI167295
– fundername: NIAID NIH HHS
  grantid: T32 AI134646
– fundername: ;
  grantid: T32AI134646; T32AI134646
GroupedDBID 0R~
53G
5VS
7RV
7X7
8C1
8FI
8FJ
AAJSJ
AASML
ABUWG
ACGFS
ADBBV
AEUYN
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BCNDV
BENPR
C6C
CCPQU
EBLON
EBS
ECGQY
FYUFA
GROUPED_DOAJ
HMCUK
HYE
K9-
KQ8
M0R
M0T
M~E
NAO
NAPCQ
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PUEGO
RNT
RPM
SNYQT
UKHRP
AAYXX
AFFHD
CITATION
ALIPV
NPM
3V.
7XB
8FK
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c541t-37f446b5b975b78a047b4a5bbaf9cc9fcee70c533e52d483269112d430bb73bf3
IEDL.DBID BENPR
ISICitedReferencesCount 15
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000991249900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2059-0105
IngestDate Fri Oct 03 12:34:09 EDT 2025
Tue Nov 04 02:07:36 EST 2025
Wed Oct 01 14:36:57 EDT 2025
Tue Oct 07 07:06:49 EDT 2025
Mon Jul 21 06:05:25 EDT 2025
Tue Nov 18 21:58:37 EST 2025
Sat Nov 29 06:30:52 EST 2025
Sun Aug 31 08:58:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-37f446b5b975b78a047b4a5bbaf9cc9fcee70c533e52d483269112d430bb73bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5150-7368
0000-0002-7571-4791
0000-0001-9040-9405
OpenAccessLink https://www.proquest.com/docview/2816242697?pq-origsite=%requestingapplication%
PMID 37210392
PQID 2816242697
PQPubID 4669711
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_764f01de94e7466ea07a9706c4bdfb7c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10199669
proquest_miscellaneous_2816759649
proquest_journals_2816242697
pubmed_primary_37210392
crossref_citationtrail_10_1038_s41541_023_00663_5
crossref_primary_10_1038_s41541_023_00663_5
springer_journals_10_1038_s41541_023_00663_5
PublicationCentury 2000
PublicationDate 2023-05-20
PublicationDateYYYYMMDD 2023-05-20
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle npj vaccines
PublicationTitleAbbrev npj Vaccines
PublicationTitleAlternate NPJ Vaccines
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Bertolotti-ciarlet (CR36) 2005; 79
Suschak (CR15) 2021; 6
Ergunay (CR35) 2014; 79
Suda (CR45) 2016; 161
Johnson (CR81) 2016; 214
Bente (CR5) 2013; 100
Mansfield (CR27) 2016; 34
De Boer, Homann, Perelson (CR75) 2003; 171
Schnell, Mebatsion, Conzelmann (CR80) 1994; 13
Rodriguez (CR9) 2019; 9
Vincent (CR46) 2003; 77
Kurup, Wirblich, Feldmann, Marzi, Schnell (CR25) 2015; 89
Haddock (CR78) 2018; 3
CR2
Estrada, De Guzman (CR30) 2011; 286
Garrison (CR32) 2017; 11
Hulswit, Paesen, Bowden, Shi (CR58) 2021; 13
Rupprecht, Nagarajan, Ertl (CR61) 2016; 15
Whitmire, Murali-Krishna, Altman, Ahmed (CR74) 2000; 355
CR4
Rappuoli (CR76) 2018; 10
CR7
Hawman (CR16) 2020; 6
Abreu-Mota (CR23) 2018; 9
Dowall, Carroll, Hewson (CR8) 2017; 35
Schnell, Buonocore, Whitt, Rose (CR39) 1996; 70
Shao (CR48) 2020; 48
Johnson, Cunningham, Fooks (CR57) 2010; 28
Schnell, Buonocore, Kretzschmar, Johnson, Rose (CR21) 1996; 93
CR83
Zivcec, Safronetz, Scott, Robertson, Feldmann (CR65) 2018; 12
McGettigan (CR38) 2003; 77
Hinkula (CR13) 2017; 91
Dowall (CR77) 2016; 11
Appelberg (CR10) 2021; 96
Keshwara (CR24) 2019; 93
Pulmanausahakul, Li, Schnell, Dietzschold (CR82) 2008; 82
Whitehouse (CR29) 2004; 64
Mousavi-Jazi, Karlberg, Papa, Christova, Mirazimi (CR11) 2012; 30
Taleghani, Bozorg, Azimi, Zamani (CR49) 2019; 127
Celis, Ou, Dietzschold, Koprowski (CR68) 1988; 62
Fischinger, Boudreau, Butler, Streeck, Alter (CR62) 2019; 41
Sanchez, Vincent, Erickson, Nichol (CR44) 2006; 80
Hudacek (CR43) 2014; 1
CR59
Smith, Yager, Baer (CR86) 1973; 48
Martin, Brady, Lew (CR54) 1998; 212
CR56
Thraenhart (CR70) 1994; 71
Bunschoten (CR71) 1989; 70
Xia (CR85) 2016; 6
Hoogstraal (CR1) 1979; 15
Smith (CR40) 2006; 353
Zivcec (CR55) 2013; 207
Kortekaas (CR33) 2015; 15
Herzog (CR69) 1992; 24
Canakoglu (CR12) 2015; 9
Moore, Wilkerson, Davis, Wyatt, Briggs (CR72) 2006; 26
Wirblich (CR42) 2017; 91
Scher, Schnell (CR19) 2020; 44
Mebatsion, Schnell, Cox, Finke, Conzelmann (CR20) 1996; 93
Harty, Brown, Hayes, Wright, Schnell (CR79) 2001; 3
Spellberg, Edwards (CR51) 2001; 32
Golden (CR37) 2019; 5
Levin (CR17) 2021; 385
Ravkov, Williams (CR73) 2009; 183
Ergönül (CR3) 2006; 6
Kurup (CR60) 2019; 220
Blaney (CR84) 2011; 85
CR28
Shearer, Dark, Chodosh, Kennedy (CR50) 1999; 6
Blaney (CR53) 2013; 9
Willet (CR22) 2015; 212
Sommerstein (CR64) 2015; 11
Aligholipour Farzani (CR14) 2019; 11
Buttigieg (CR18) 2014; 9
Plummer, McGettigan (CR41) 2019; 13
Freitas (CR31) 2020; 16
Hernandez (CR47) 2019; 47
Gray, Dautel, Estrada-Pena, Kahl, Lindgren (CR6) 2009; 200
Iijima, Mattei, Iwasaki (CR52) 2010; 108
Reynard (CR63) 2009; 83
Celis, Miller, Wiktor, Dietzschold, Koprowski (CR67) 1986; 136
Fels (CR34) 2021; 184
Geisbert (CR26) 2008; 26
Leventhal (CR66) 2022; 82
E Haddock (663_CR78) 2018; 3
DA Bente (663_CR5) 2013; 100
D Kurup (663_CR60) 2019; 220
M Willet (663_CR22) 2015; 212
663_CR83
JK Whitmire (663_CR74) 2000; 355
JS Gray (663_CR6) 2009; 200
N Iijima (663_CR52) 2010; 108
T Aligholipour Farzani (663_CR14) 2019; 11
CE Rupprecht (663_CR61) 2016; 15
H Hoogstraal (663_CR1) 1979; 15
SE Rodriguez (663_CR9) 2019; 9
MJ Schnell (663_CR21) 1996; 93
T Abreu-Mota (663_CR23) 2018; 9
B Spellberg (663_CR51) 2001; 32
EG Levin (663_CR17) 2021; 385
R Rappuoli (663_CR76) 2018; 10
E Celis (663_CR68) 1988; 62
ME Smith (663_CR40) 2006; 353
DF Estrada (663_CR30) 2011; 286
J Hinkula (663_CR13) 2017; 91
JJ Suschak (663_CR15) 2021; 6
A Hernandez (663_CR47) 2019; 47
H Bunschoten (663_CR71) 1989; 70
A Bertolotti-ciarlet (663_CR36) 2005; 79
K Ergunay (663_CR35) 2014; 79
H Xia (663_CR85) 2016; 6
663_CR28
N Taleghani (663_CR49) 2019; 127
O Thraenhart (663_CR70) 1994; 71
J Kortekaas (663_CR33) 2015; 15
MH Shearer (663_CR50) 1999; 6
SM Moore (663_CR72) 2006; 26
RJG Hulswit (663_CR58) 2021; 13
S Fischinger (663_CR62) 2019; 41
R Sommerstein (663_CR64) 2015; 11
N Canakoglu (663_CR12) 2015; 9
N Freitas (663_CR31) 2020; 16
SS Leventhal (663_CR66) 2022; 82
Y Suda (663_CR45) 2016; 161
N Johnson (663_CR57) 2010; 28
KR Buttigieg (663_CR18) 2014; 9
TW Geisbert (663_CR26) 2008; 26
E Celis (663_CR67) 1986; 136
O Reynard (663_CR63) 2009; 83
T Mebatsion (663_CR20) 1996; 93
S Shao (663_CR48) 2020; 48
MJ Schnell (663_CR80) 1994; 13
R Keshwara (663_CR24) 2019; 93
RF Johnson (663_CR81) 2016; 214
JE Blaney (663_CR84) 2011; 85
G Scher (663_CR19) 2020; 44
JW Golden (663_CR37) 2019; 5
MJ Schnell (663_CR39) 1996; 70
C Wirblich (663_CR42) 2017; 91
JM Fels (663_CR34) 2021; 184
KL Mansfield (663_CR27) 2016; 34
Ö Ergönül (663_CR3) 2006; 6
RJ De Boer (663_CR75) 2003; 171
JE Blaney (663_CR53) 2013; 9
M Zivcec (663_CR65) 2018; 12
S Appelberg (663_CR10) 2021; 96
M Herzog (663_CR69) 1992; 24
D Kurup (663_CR25) 2015; 89
663_CR2
663_CR4
DW Hawman (663_CR16) 2020; 6
MJ Vincent (663_CR46) 2003; 77
RM Martin (663_CR54) 1998; 212
CA Whitehouse (663_CR29) 2004; 64
JP McGettigan (663_CR38) 2003; 77
663_CR7
663_CR56
EV Ravkov (663_CR73) 2009; 183
AR Garrison (663_CR32) 2017; 11
663_CR59
R Pulmanausahakul (663_CR82) 2008; 82
RN Harty (663_CR79) 2001; 3
AJ Sanchez (663_CR44) 2006; 80
SD Dowall (663_CR8) 2017; 35
M Mousavi-Jazi (663_CR11) 2012; 30
JR Plummer (663_CR41) 2019; 13
JS Smith (663_CR86) 1973; 48
AW Hudacek (663_CR43) 2014; 1
M Zivcec (663_CR55) 2013; 207
SD Dowall (663_CR77) 2016; 11
References_xml – volume: 9
  start-page: 7755
  year: 2019
  end-page: 7755
  ident: CR9
  article-title: Vesicular stomatitis virus-based vaccine protects mice against Crimean-Congo hemorrhagic fever
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-44210-6
– volume: 82
  start-page: 104188
  year: 2022
  ident: CR66
  article-title: Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge
  publication-title: eBioMedicine
  doi: 10.1016/j.ebiom.2022.104188
– volume: 9
  start-page: e0003579
  year: 2015
  end-page: e0003579
  ident: CR12
  article-title: Immunization of Knock-Out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0003579
– volume: 35
  start-page: 6015
  year: 2017
  end-page: 6023
  ident: CR8
  article-title: Development of vaccines against Crimean-Congo haemorrhagic fever virus
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.05.031
– ident: CR4
– volume: 200
  start-page: 593232
  year: 2009
  ident: CR6
  article-title: Effects of climate change on ticks and tick-borne diseases in europe
  publication-title: Interdiscip. Perspect. Infect. Dis.
– volume: 77
  start-page: 8640 LP
  year: 2003
  end-page: 8648649
  ident: CR46
  article-title: Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.16.8640-8649.2003
– volume: 26
  start-page: 533
  year: 2006
  end-page: 545
  ident: CR72
  article-title: Detection of cellular immunity to rabies antigens in human vaccinees
  publication-title: J. Clin. Immunol.
  doi: 10.1007/s10875-006-9044-0
– volume: 6
  start-page: 35819
  year: 2016
  end-page: 35819
  ident: CR85
  article-title: Transstadial transmission and long-term association of Crimean-Congo hemorrhagic fever virus in ticks shapes genome plasticity
  publication-title: Sci. Rep.
  doi: 10.1038/srep35819
– volume: 108
  start-page: 284
  year: 2010
  end-page: 289
  ident: CR52
  article-title: Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue
  publication-title: PNAS
  doi: 10.1073/pnas.1005201108
– volume: 220
  start-page: 1521
  year: 2019
  end-page: 1528
  ident: CR60
  article-title: Inactivated rabies virus-based Ebola vaccine preserved by vaporization is heat-stable and immunogenic against Ebola and protects against rabies challenge
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiz332
– volume: 96
  start-page: e0156821
  year: 2021
  ident: CR10
  article-title: Nucleoside-modified mRNA vaccines protect IFNAR -/- mice against Crimean Congo hemorrhagic fever virus infection
  publication-title: J. Virol.
  doi: 10.1128/jvi.01568-21
– volume: 9
  start-page: e1003389
  year: 2013
  end-page: e1003389
  ident: CR53
  article-title: Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine
  publication-title: PLoS Pathogens
  doi: 10.1371/journal.ppat.1003389
– volume: 15
  start-page: 759
  year: 2015
  end-page: 764
  ident: CR33
  article-title: Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice
  publication-title: Vector Borne Zoonotic Dis.
  doi: 10.1089/vbz.2015.1855
– volume: 5
  start-page: eaaw9535
  year: 2019
  end-page: eaaw9535
  ident: CR37
  article-title: GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aaw9535
– volume: 11
  start-page: 75
  year: 2019
  ident: CR14
  article-title: Co-delivery effect of CD24 on the immunogenicity and lethal challenge protection of a DNA vector expressing nucleocapsid protein of crimean congo hemorrhagic fever virus
  publication-title: Viruses
  doi: 10.3390/v11010075
– volume: 214
  start-page: S342
  year: 2016
  end-page: S354
  ident: CR81
  article-title: An inactivated rabies virus-based Ebola vaccine, FILORAB1, adjuvanted with glucopyranosyl lipid A in stable emulsion confers complete protection in nonhuman primate challenge models
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiw231
– volume: 91
  start-page: e02040
  year: 2017
  end-page: 02016
  ident: CR42
  article-title: One-health: a safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.02040-16
– volume: 184
  start-page: 3486
  year: 2021
  end-page: 3501.e21
  ident: CR34
  article-title: Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
  publication-title: Cell
  doi: 10.1016/j.cell.2021.05.001
– volume: 9
  start-page: 4223
  year: 2018
  end-page: 4223
  ident: CR23
  article-title: Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-06741-w
– volume: 171
  start-page: 3928
  year: 2003
  end-page: 3935
  ident: CR75
  article-title: Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.171.8.3928
– volume: 3
  start-page: 513
  year: 2001
  end-page: 517
  ident: CR79
  article-title: Vaccinia virus-free recovery of vesicular stomatitis virus
  publication-title: J. Mol. Microbiol. Biotechnol.
– volume: 6
  start-page: 203
  year: 2006
  end-page: 214
  ident: CR3
  article-title: Crimean-Congo haemorrhagic fever
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(06)70435-2
– volume: 48
  start-page: 1991
  year: 2020
  end-page: 2001
  ident: CR48
  article-title: An engineered biomimetic MPER peptide vaccine induces weakly HIV neutralizing Antibodies in Mice
  publication-title: Ann. Biomed. Eng.
  doi: 10.1007/s10439-019-02398-8
– volume: 13
  start-page: e0007800
  year: 2019
  end-page: e0007800
  ident: CR41
  article-title: Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0007800
– volume: 1
  start-page: 14046
  year: 2014
  end-page: 14046
  ident: CR43
  article-title: Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo
  publication-title: Mol. Ther. Methods Clin. Dev.
  doi: 10.1038/mtm.2014.46
– volume: 207
  start-page: 1909
  year: 2013
  end-page: 1921
  ident: CR55
  article-title: Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jit061
– volume: 62
  start-page: 3128
  year: 1988
  end-page: 3134
  ident: CR68
  article-title: Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients
  publication-title: J. Virol.
  doi: 10.1128/jvi.62.9.3128-3134.1988
– volume: 77
  start-page: 237 LP
  year: 2003
  end-page: 237244
  ident: CR38
  article-title: Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.1.237-244.2003
– volume: 15
  start-page: 307
  year: 1979
  end-page: 417
  ident: CR1
  article-title: The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa
  publication-title: J. Med. Entomol.
  doi: 10.1093/jmedent/15.4.307
– volume: 183
  start-page: 2382
  year: 2009
  end-page: 2389
  ident: CR73
  article-title: The magnitude of CD4+ T cell recall responses is controlled by the duration of the secondary stimulus
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900319
– volume: 9
  start-page: e91516
  year: 2014
  end-page: e91516
  ident: CR18
  article-title: A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0091516
– volume: 10
  start-page: eaat4615
  year: 2018
  ident: CR76
  article-title: Glycoconjugate vaccines: principles and mechanisms
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aat4615
– volume: 32
  start-page: 76
  year: 2001
  end-page: 102
  ident: CR51
  article-title: Type 1/Type 2 immunity in infectious diseases
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/317537
– volume: 89
  start-page: 144
  year: 2015
  end-page: 154
  ident: CR25
  article-title: Rhabdovirus-based vaccine platforms against henipaviruses
  publication-title: J. Virol.
  doi: 10.1128/JVI.02308-14
– volume: 11
  start-page: e0005908
  year: 2017
  end-page: e0005908
  ident: CR32
  article-title: A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
  publication-title: PLoS Negl.Trop. Dis.
  doi: 10.1371/journal.pntd.0005908
– volume: 83
  start-page: 9596
  year: 2009
  end-page: 9601
  ident: CR63
  article-title: Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins
  publication-title: J. Virol
  doi: 10.1128/JVI.00784-09
– volume: 79
  start-page: 6152
  year: 2005
  end-page: 6161
  ident: CR36
  article-title: Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins
  publication-title: Society
– volume: 13
  start-page: 353
  year: 2021
  ident: CR58
  article-title: Recent advances in bunyavirus glycoprotein research: precursor processing, receptor binding and structure
  publication-title: Viruses
  doi: 10.3390/v13020353
– volume: 15
  start-page: 731
  year: 2016
  end-page: 749
  ident: CR61
  article-title: Current status and development of vaccines and other biologics for human rabies prevention
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2016.1140040
– volume: 44
  start-page: 169
  year: 2020
  end-page: 182
  ident: CR19
  article-title: Rhabdoviruses as vectors for vaccines and therapeutics
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2020.09.003
– volume: 79
  start-page: 31
  year: 2014
  end-page: 36
  ident: CR35
  article-title: Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: a comprehensive analysis during the early stages of the infection
  publication-title: Diagn. Microbiol. Infect. Dis.
  doi: 10.1016/j.diagmicrobio.2013.12.015
– ident: CR2
– volume: 6
  start-page: 953
  year: 1999
  end-page: 958
  ident: CR50
  article-title: Comparison and characterization of immunoglobulin G subclasses among primate species
  publication-title: Clin. Vaccine Immunol.
– volume: 355
  start-page: 373
  year: 2000
  end-page: 379
  ident: CR74
  article-title: Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements
  publication-title: Philos Trans R Soc. Lond B Biol. Sci.
  doi: 10.1098/rstb.2000.0577
– volume: 80
  start-page: 514 LP
  year: 2006
  end-page: 514525
  ident: CR44
  article-title: Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein
  publication-title: J. Virol.
  doi: 10.1128/JVI.80.1.514-525.2006
– volume: 85
  start-page: 10605
  year: 2011
  end-page: 10616
  ident: CR84
  article-title: Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses
  publication-title: J. Virol.
  doi: 10.1128/JVI.00558-11
– volume: 93
  start-page: 7310
  year: 1996
  end-page: 7314
  ident: CR20
  article-title: Highly stable expression of a foreign gene from rabies virus vectors
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.93.14.7310
– volume: 286
  start-page: 21678
  year: 2011
  end-page: 21686
  ident: CR30
  article-title: Structural characterization of the Crimean-Congo hemorrhagic fever virus Gn tail provides insight into virus assembly
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.216515
– volume: 13
  start-page: 4195
  year: 1994
  end-page: 4203
  ident: CR80
  article-title: Infectious rabies viruses from cloned cDNA
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06739.x
– volume: 12
  start-page: 1
  year: 2018
  end-page: 14
  ident: CR65
  article-title: Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0006628
– volume: 93
  start-page: e01865
  year: 2019
  end-page: 01818
  ident: CR24
  article-title: A recombinant rabies virus expressing the marburg virus glycoprotein is dependent upon antibody-mediated cellular cytotoxicity for protection against Marburg virus disease in a murine model
  publication-title: J. Virol.
  doi: 10.1128/JVI.01865-18
– volume: 34
  start-page: 5959
  year: 2016
  end-page: 5967
  ident: CR27
  article-title: Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.09.058
– volume: 47
  start-page: e930
  year: 2019
  end-page: e938
  ident: CR47
  article-title: Phosphorylated hexa-acyl disaccharides augment host resistance against common nosocomial pathogens
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000003967
– ident: CR56
– volume: 28
  start-page: 3896
  year: 2010
  end-page: 3901
  ident: CR57
  article-title: The immune response to rabies virus infection and vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.03.039
– volume: 100
  start-page: 159
  year: 2013
  end-page: 189
  ident: CR5
  article-title: Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2013.07.006
– volume: 136
  start-page: 692
  year: 1986
  end-page: 697
  ident: CR67
  article-title: Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.136.2.692
– volume: 16
  start-page: e1008850
  year: 2020
  end-page: e1008850
  ident: CR31
  article-title: The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity
  publication-title: PLoS Pathogens
  doi: 10.1371/journal.ppat.1008850
– volume: 11
  start-page: e1005276
  year: 2015
  ident: CR64
  article-title: Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection
  publication-title: PLOS Pathogens
  doi: 10.1371/journal.ppat.1005276
– volume: 6
  start-page: 31
  year: 2021
  end-page: 31
  ident: CR15
  article-title: A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00293-9
– volume: 24
  start-page: 77
  year: 1992
  end-page: 89
  ident: CR69
  article-title: Nucleocapsid specific T and B cell responses in humans after rabies vaccination
  publication-title: Virus Research
  doi: 10.1016/0168-1702(92)90032-5
– volume: 64
  start-page: 145
  year: 2004
  end-page: 160
  ident: CR29
  article-title: Crimean–Congo hemorrhagic fever
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2004.08.001
– volume: 70
  start-page: 1513
  year: 1989
  end-page: 1521
  ident: CR71
  article-title: Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-70-6-1513
– volume: 212
  start-page: S414
  year: 2015
  end-page: S424
  ident: CR22
  article-title: Preclinical development of inactivated rabies virus–based polyvalent vaccine against rabies and filoviruses
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv251
– volume: 71
  start-page: 287
  year: 1994
  end-page: 292
  ident: CR70
  article-title: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man
  publication-title: Clin. Immunol. Immunopathol.
  doi: 10.1006/clin.1994.1088
– volume: 3
  start-page: 556
  year: 2018
  end-page: 562
  ident: CR78
  article-title: A cynomolgus macaque model for Crimean-Congo haemorrhagic fever
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0141-7
– volume: 353
  start-page: 344
  year: 2006
  end-page: 356
  ident: CR40
  article-title: Rabies virus glycoprotein as a carrier for anthrax protective antigen
  publication-title: Virology
  doi: 10.1016/j.virol.2006.05.010
– volume: 41
  start-page: 239
  year: 2019
  end-page: 249
  ident: CR62
  article-title: Sex differences in vaccine-induced humoral immunity
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-018-0726-5
– volume: 127
  start-page: 150
  year: 2019
  end-page: 157
  ident: CR49
  article-title: Immunogenicity of HPV and HBV vaccines: adjuvanticity of synthetic analogs of monophosphoryl lipid A combined with aluminum hydroxide
  publication-title: APMIS
  doi: 10.1111/apm.12927
– volume: 48
  start-page: 535
  year: 1973
  end-page: 541
  ident: CR86
  article-title: A rapid reproducible test for determining rabies neutralizing antibody
  publication-title: Bull. World Health Organ.
– volume: 70
  start-page: 2318
  year: 1996
  end-page: 2323
  ident: CR39
  article-title: The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus
  publication-title: J. Virol.
  doi: 10.1128/jvi.70.4.2318-2323.1996
– ident: CR7
– volume: 212
  start-page: 187
  year: 1998
  end-page: 192
  ident: CR54
  article-title: The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice
  publication-title: J. Immunol. Methods
  doi: 10.1016/S0022-1759(98)00015-5
– ident: CR59
– ident: CR83
– volume: 6
  start-page: 187
  year: 2020
  end-page: 195
  ident: CR16
  article-title: A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-00815-6
– volume: 93
  start-page: 11359
  year: 1996
  end-page: 11365
  ident: CR21
  article-title: Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.93.21.11359
– volume: 11
  start-page: e0156637
  year: 2016
  end-page: e0156637
  ident: CR77
  article-title: Protective effects of a modified vaccinia ankara-based vaccine candidate against Crimean-Congo haemorrhagic fever virus require both cellular and humoral responses
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156637
– ident: CR28
– volume: 26
  start-page: 6894
  year: 2008
  end-page: 6900
  ident: CR26
  article-title: Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.09.082
– volume: 82
  start-page: 2330 LP
  year: 2008
  end-page: 2332338
  ident: CR82
  article-title: The Glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread
  publication-title: J. Virol.
  doi: 10.1128/JVI.02327-07
– volume: 30
  start-page: 6225
  year: 2012
  end-page: 6229
  ident: CR11
  article-title: Healthy individuals’ immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.08.003
– volume: 91
  start-page: 1
  year: 2017
  end-page: 19
  ident: CR13
  article-title: Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and / or virus-like particles
  publication-title: J. Virol.
  doi: 10.1128/JVI.02076-16
– volume: 385
  start-page: e84
  year: 2021
  ident: CR17
  article-title: Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2114583
– volume: 161
  start-page: 1447
  year: 2016
  end-page: 1454
  ident: CR45
  article-title: Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-016-2803-1
– volume: 11
  start-page: e0156637
  year: 2016
  ident: 663_CR77
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156637
– volume: 3
  start-page: 556
  year: 2018
  ident: 663_CR78
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-018-0141-7
– ident: 663_CR83
  doi: 10.1016/B978-0-12-144730-4.50019-9
– volume: 214
  start-page: S342
  year: 2016
  ident: 663_CR81
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiw231
– volume: 82
  start-page: 2330 LP
  year: 2008
  ident: 663_CR82
  publication-title: J. Virol.
  doi: 10.1128/JVI.02327-07
– volume: 89
  start-page: 144
  year: 2015
  ident: 663_CR25
  publication-title: J. Virol.
  doi: 10.1128/JVI.02308-14
– volume: 9
  start-page: e0003579
  year: 2015
  ident: 663_CR12
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0003579
– volume: 64
  start-page: 145
  year: 2004
  ident: 663_CR29
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2004.08.001
– volume: 286
  start-page: 21678
  year: 2011
  ident: 663_CR30
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.216515
– volume: 15
  start-page: 731
  year: 2016
  ident: 663_CR61
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2016.1140040
– ident: 663_CR28
– volume: 385
  start-page: e84
  year: 2021
  ident: 663_CR17
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2114583
– volume: 13
  start-page: 353
  year: 2021
  ident: 663_CR58
  publication-title: Viruses
  doi: 10.3390/v13020353
– volume: 11
  start-page: 75
  year: 2019
  ident: 663_CR14
  publication-title: Viruses
  doi: 10.3390/v11010075
– volume: 6
  start-page: 953
  year: 1999
  ident: 663_CR50
  publication-title: Clin. Vaccine Immunol.
– volume: 136
  start-page: 692
  year: 1986
  ident: 663_CR67
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.136.2.692
– volume: 77
  start-page: 8640 LP
  year: 2003
  ident: 663_CR46
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.16.8640-8649.2003
– volume: 26
  start-page: 533
  year: 2006
  ident: 663_CR72
  publication-title: J. Clin. Immunol.
  doi: 10.1007/s10875-006-9044-0
– volume: 26
  start-page: 6894
  year: 2008
  ident: 663_CR26
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.09.082
– volume: 48
  start-page: 1991
  year: 2020
  ident: 663_CR48
  publication-title: Ann. Biomed. Eng.
  doi: 10.1007/s10439-019-02398-8
– volume: 11
  start-page: e1005276
  year: 2015
  ident: 663_CR64
  publication-title: PLOS Pathogens
  doi: 10.1371/journal.ppat.1005276
– ident: 663_CR7
  doi: 10.3389/fphys.2012.00064
– ident: 663_CR4
  doi: 10.1097/QCO.0b013e3282a56a0a
– volume: 212
  start-page: S414
  year: 2015
  ident: 663_CR22
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv251
– volume: 355
  start-page: 373
  year: 2000
  ident: 663_CR74
  publication-title: Philos Trans R Soc. Lond B Biol. Sci.
  doi: 10.1098/rstb.2000.0577
– volume: 200
  start-page: 593232
  year: 2009
  ident: 663_CR6
  publication-title: Interdiscip. Perspect. Infect. Dis.
– volume: 41
  start-page: 239
  year: 2019
  ident: 663_CR62
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-018-0726-5
– volume: 15
  start-page: 759
  year: 2015
  ident: 663_CR33
  publication-title: Vector Borne Zoonotic Dis.
  doi: 10.1089/vbz.2015.1855
– volume: 220
  start-page: 1521
  year: 2019
  ident: 663_CR60
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiz332
– volume: 6
  start-page: 35819
  year: 2016
  ident: 663_CR85
  publication-title: Sci. Rep.
  doi: 10.1038/srep35819
– ident: 663_CR2
– volume: 13
  start-page: e0007800
  year: 2019
  ident: 663_CR41
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0007800
– volume: 207
  start-page: 1909
  year: 2013
  ident: 663_CR55
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jit061
– volume: 127
  start-page: 150
  year: 2019
  ident: 663_CR49
  publication-title: APMIS
  doi: 10.1111/apm.12927
– volume: 184
  start-page: 3486
  year: 2021
  ident: 663_CR34
  publication-title: Cell
  doi: 10.1016/j.cell.2021.05.001
– volume: 28
  start-page: 3896
  year: 2010
  ident: 663_CR57
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.03.039
– volume: 80
  start-page: 514 LP
  year: 2006
  ident: 663_CR44
  publication-title: J. Virol.
  doi: 10.1128/JVI.80.1.514-525.2006
– volume: 9
  start-page: e1003389
  year: 2013
  ident: 663_CR53
  publication-title: PLoS Pathogens
  doi: 10.1371/journal.ppat.1003389
– volume: 82
  start-page: 104188
  year: 2022
  ident: 663_CR66
  publication-title: eBioMedicine
  doi: 10.1016/j.ebiom.2022.104188
– volume: 11
  start-page: e0005908
  year: 2017
  ident: 663_CR32
  publication-title: PLoS Negl.Trop. Dis.
  doi: 10.1371/journal.pntd.0005908
– volume: 77
  start-page: 237 LP
  year: 2003
  ident: 663_CR38
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.1.237-244.2003
– ident: 663_CR59
– volume: 47
  start-page: e930
  year: 2019
  ident: 663_CR47
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000003967
– volume: 212
  start-page: 187
  year: 1998
  ident: 663_CR54
  publication-title: J. Immunol. Methods
  doi: 10.1016/S0022-1759(98)00015-5
– volume: 35
  start-page: 6015
  year: 2017
  ident: 663_CR8
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.05.031
– volume: 34
  start-page: 5959
  year: 2016
  ident: 663_CR27
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.09.058
– volume: 83
  start-page: 9596
  year: 2009
  ident: 663_CR63
  publication-title: J. Virol
  doi: 10.1128/JVI.00784-09
– volume: 100
  start-page: 159
  year: 2013
  ident: 663_CR5
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2013.07.006
– volume: 62
  start-page: 3128
  year: 1988
  ident: 663_CR68
  publication-title: J. Virol.
  doi: 10.1128/jvi.62.9.3128-3134.1988
– volume: 1
  start-page: 14046
  year: 2014
  ident: 663_CR43
  publication-title: Mol. Ther. Methods Clin. Dev.
  doi: 10.1038/mtm.2014.46
– volume: 9
  start-page: e91516
  year: 2014
  ident: 663_CR18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0091516
– volume: 91
  start-page: e02040
  year: 2017
  ident: 663_CR42
  publication-title: J. Virol.
  doi: 10.1128/JVI.02040-16
– volume: 15
  start-page: 307
  year: 1979
  ident: 663_CR1
  publication-title: J. Med. Entomol.
  doi: 10.1093/jmedent/15.4.307
– volume: 16
  start-page: e1008850
  year: 2020
  ident: 663_CR31
  publication-title: PLoS Pathogens
  doi: 10.1371/journal.ppat.1008850
– volume: 6
  start-page: 187
  year: 2020
  ident: 663_CR16
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-00815-6
– volume: 108
  start-page: 284
  year: 2010
  ident: 663_CR52
  publication-title: PNAS
  doi: 10.1073/pnas.1005201108
– volume: 13
  start-page: 4195
  year: 1994
  ident: 663_CR80
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06739.x
– volume: 48
  start-page: 535
  year: 1973
  ident: 663_CR86
  publication-title: Bull. World Health Organ.
– volume: 79
  start-page: 31
  year: 2014
  ident: 663_CR35
  publication-title: Diagn. Microbiol. Infect. Dis.
  doi: 10.1016/j.diagmicrobio.2013.12.015
– volume: 30
  start-page: 6225
  year: 2012
  ident: 663_CR11
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.08.003
– volume: 44
  start-page: 169
  year: 2020
  ident: 663_CR19
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2020.09.003
– volume: 6
  start-page: 31
  year: 2021
  ident: 663_CR15
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00293-9
– volume: 93
  start-page: 11359
  year: 1996
  ident: 663_CR21
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.93.21.11359
– volume: 9
  start-page: 4223
  year: 2018
  ident: 663_CR23
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-06741-w
– volume: 12
  start-page: 1
  year: 2018
  ident: 663_CR65
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0006628
– volume: 6
  start-page: 203
  year: 2006
  ident: 663_CR3
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(06)70435-2
– volume: 70
  start-page: 1513
  year: 1989
  ident: 663_CR71
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-70-6-1513
– volume: 10
  start-page: eaat4615
  year: 2018
  ident: 663_CR76
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aat4615
– volume: 32
  start-page: 76
  year: 2001
  ident: 663_CR51
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/317537
– volume: 171
  start-page: 3928
  year: 2003
  ident: 663_CR75
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.171.8.3928
– volume: 70
  start-page: 2318
  year: 1996
  ident: 663_CR39
  publication-title: J. Virol.
  doi: 10.1128/jvi.70.4.2318-2323.1996
– volume: 161
  start-page: 1447
  year: 2016
  ident: 663_CR45
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-016-2803-1
– volume: 24
  start-page: 77
  year: 1992
  ident: 663_CR69
  publication-title: Virus Research
  doi: 10.1016/0168-1702(92)90032-5
– volume: 71
  start-page: 287
  year: 1994
  ident: 663_CR70
  publication-title: Clin. Immunol. Immunopathol.
  doi: 10.1006/clin.1994.1088
– volume: 9
  start-page: 7755
  year: 2019
  ident: 663_CR9
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-44210-6
– volume: 5
  start-page: eaaw9535
  year: 2019
  ident: 663_CR37
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aaw9535
– volume: 353
  start-page: 344
  year: 2006
  ident: 663_CR40
  publication-title: Virology
  doi: 10.1016/j.virol.2006.05.010
– volume: 93
  start-page: e01865
  year: 2019
  ident: 663_CR24
  publication-title: J. Virol.
  doi: 10.1128/JVI.01865-18
– volume: 3
  start-page: 513
  year: 2001
  ident: 663_CR79
  publication-title: J. Mol. Microbiol. Biotechnol.
– ident: 663_CR56
  doi: 10.4049/jimmunol.0800596
– volume: 91
  start-page: 1
  year: 2017
  ident: 663_CR13
  publication-title: J. Virol.
  doi: 10.1128/JVI.02076-16
– volume: 183
  start-page: 2382
  year: 2009
  ident: 663_CR73
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900319
– volume: 96
  start-page: e0156821
  year: 2021
  ident: 663_CR10
  publication-title: J. Virol.
  doi: 10.1128/jvi.01568-21
– volume: 93
  start-page: 7310
  year: 1996
  ident: 663_CR20
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.93.14.7310
– volume: 79
  start-page: 6152
  year: 2005
  ident: 663_CR36
  publication-title: Society
– volume: 85
  start-page: 10605
  year: 2011
  ident: 663_CR84
  publication-title: J. Virol.
  doi: 10.1128/JVI.00558-11
SSID ssj0001763570
Score 2.3130047
Snippet Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for effective...
Abstract Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. There is a great need for...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 73
SubjectTerms 631/250/590/1883
631/326/596/2561
Biomedical and Life Sciences
Biomedicine
Glycoproteins
Hemorrhage
Infectious Diseases
Medical Microbiology
Monoclonal antibodies
Parasitic diseases
Public Health
Rodents
Vaccine
Vaccines
Viral infections
Virology
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFH9CEwcuiG8CAxkJ7UKjObEdx0c2MThNPQxpN8t2bFoJpVPTVtp_z7OdtiufF25R7ETO-3559u8BvK9qg3EB9aXhzpTcVLxUyouyRSWnIUKyhZCaTcjLy_b6Wk3vtPqKe8IyPHAm3KlseKBV5xX3kjeNN1QaJWnjuO2ClS5aX4x67iRT6e9Kwlmj4ykZytrTAT0Vx8y5ZmVys6U48EQJsP93UeavmyV_qpgmR3TxCB6OEST5mFf-GO75_gmcTDME9e2EXO1PVA0TckKme3Dq26dw9nnKWmIGYsjGuFhVJ3kzOMHolcQmX9705fmi_7Ygs7gLdzkzaBxJ8CjzZDNfrodn8PXi09X5l3Lso1A6_OQV2pCASZ8VVklhZWsol5YbYa0JyjkV0E9K6jDu86LuOKp4gxYQrxi1VjIb2HM46he9fwmEcWU7zKdd0yneqUo5IZjDnEgZ5pxwBVRbmmo3gozHXhffdSp2s1ZnPmjkg0580KKAD7tnbjLExl9nn0VW7WZGeOx0A4VGj0Kj_yU0BRxvGa1HnR103VZNOtkrC3i3G0ZtiyUU0_vFOs-RQjVcFfAiy8VuJQyTaYrhZgHtgcQcLPVwpJ_PEqI32sWYd-JLJ1vh2q_rz7R49T9o8Roe1EkrBFrMYzhaLdf-Ddx3m9V8WL5NavUDeOwjzw
  priority: 102
  providerName: Directory of Open Access Journals
Title GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus
URI https://link.springer.com/article/10.1038/s41541-023-00663-5
https://www.ncbi.nlm.nih.gov/pubmed/37210392
https://www.proquest.com/docview/2816242697
https://www.proquest.com/docview/2816759649
https://pubmed.ncbi.nlm.nih.gov/PMC10199669
https://doaj.org/article/764f01de94e7466ea07a9706c4bdfb7c
Volume 8
WOSCitedRecordID wos000991249900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M~E
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Consumer Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0R
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Healthcare Administration Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0T
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7RV
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: BENPR
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7X7
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 8C1
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: PIMPY
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLdYx4EL34zAqIyEdqHRnNqO4xOi1QYcVkVVQeUU2Y6zVkLJSNpK--95dtJW5WMXLk9R7EROnt-Xn_17CL2Lhgr8AmJDxYwKmYpYKKXlYQJCTgoHyVYUvtiEmEyS-Vym3YJb022r3OpEr6jzyrg18vNhEsX-3KX4cPMzdFWjXHa1K6FxhI4dUhnroePRxSSd7ldZPN4a6U7LEJqcN2CxGETQQxp6cxvyA4vkgfv_5m3-uWnyt8ypN0iXj_73Ux6jh50rij-2c-cJumfLp-gsbbGsbwd4tj-a1QzwGU73KNe3z9DoU0oTrBqs8EYZl57H7a5yDG4wdtXCrCrDcVVeV3jhtvPWCwVaFhcWhAdvlvW6eY6-Xl7Mxp_DriBDaOCfrUAZFRA9aq6l4FokijChmeJaq0IaIwswuIIYcCAtH-YMdEUMqhSuKNFaUF3QF6hXVqV9iTBlUucQmJs4lyyXkTScUwPBlVTUGG4CFG2ZkpkOrdwVzfiR-aw5TbKWkRkwMvOMzHiA3u-euWmxOu7sPXK83vV0ONv-RlVfZ53YZiJmBYlyK5kVLI6tIkJJQWLDdF5oAcM83bI464S_yfb8DdDbXTOIrcvFqNJW67aP4DJmMkAn7cTajYRCVE7Abw1QcjDlDoZ62FIuFx4aHBSsC2DhpYPt7NyP69__4tXdn_EaPRh6geGgVE9Rb1Wv7Rt032xWy6buoyMx_eboXHiaAE3GUb-Txb5f5gB6RaaezqAl_XKVfv8F5u463Q
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQIIX7pfCACPBXmg0J7bj-AEhNhibdlEfirQ3YzvOWgklo2mL-qf4jRw7Saty2dseeItix3KS79zs4-8g9DpONPgFxEWaWR0xHbNISsejDIScFJ6SrShCsQlxepqdncnBBvrZnYXxaZWdTgyKOq-sXyPfSbI4DecuxfuL75GvGuV3V7sSGg0sjtziB4Rs9bvDj_B_3yTJ_qfh3kHUVhWILGfxFCSqgBDIcCMFNyLThAnDNDdGF9JaWYDVEMSCF-R4kjMAfAr6AK4oMUZQU1AY9xq67nn1fArhCRmu1nQCuxtpz-YQmu3UYB8ZxOsJjYJxj_ia_QtlAv7m2_6ZovnbPm0wf_t3_rcPdxfdbh1t_KGRjHtow5X30fagYepe9PFwdfCs7uNtPFhxeC8eoN3PA5phXWON59r65APc5MxjcPKxr4XmdBntVeV5hUc-WXky0mBDcOFANeD5eDKrH6IvV_J-j9BmWZXuCcKUSZNLImyaS5bLWFrOqYXQUWpqLbc9FHcgULblYvclQb6pkBNAM9UARwFwVACO4j30dvnMRcNEcmnvXY-tZU_PIh5uVJNz1SolJVJWkDh3kjnB0tRpIrQUJLXM5IURMM2tDlKqVW21WuGph14tm0Ep-Z0mXbpq1vQRXKZM9tDjBsjLmVCR-PSDpIeyNYivTXW9pRyPAvE5mA8fnsOg_U4aVvP697d4evlrvEQ3D4Ynx-r48PToGbqVBGHlYD620OZ0MnPP0Q07n47ryYsg7Rh9vWop-QVfZY6L
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GP38+as+a+vaccine+target+for+Crimean-Congo+hemorrhagic+fever+virus&rft.jtitle=npj+vaccines&rft.au=Scher%2C+Gabrielle&rft.au=Bente%2C+Dennis+A&rft.au=Mears%2C+Megan+C&rft.au=Cajimat%2C+Maria+N+B&rft.date=2023-05-20&rft.issn=2059-0105&rft.eissn=2059-0105&rft.volume=8&rft.issue=1&rft.spage=73&rft_id=info:doi/10.1038%2Fs41541-023-00663-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-0105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-0105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-0105&client=summon